Covid-19 Research

Review Article

A Review: Artemisinin-Based Combination Therapies [ACTs] and K13 Polymorphism

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Biology Group
OCLC 8657511183
Aqeel Ahmad and Sultan Ahmad*
Issue: Volume1-Issue4
Pages: 088-091
Received: 2020-07-27
Accepted: 2020-08-12
Published: 2020-08-13

Abstract

Malaria is caused by four plasmodium species in humans (P. falciparum, P. vivax, P. malariae and P. ovale) which spread from one person to another via the bite of female Anopheles mosquito. P. falciparum causes most deaths from malaria [1] and is most prevalent on the African continent whereas P. vivax has a wider geographical distribution [2]. According to the latest WHO estimates, released in December 2015, there were 214 million cases of malaria in 2015 and 438,000 deaths [3]. Existing strategies to control malaria include vector control, chemoprevention and case management [4]. Without a fruitful antibody that would offer security against malaria, we have to depend on anti-malarial prescription to treat just as lessen the odds of getting the disease [5-8]. Artemisinin in mix with other moderate acting medications is suggested for the treatment of P. falciparum [9,10].

FullText HTML FullText PDF DOI: 10.37871/jels1124 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2020 Ahmad A, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Ahmad A, Ahmad S. A Review: Artemisinin-Based Combination Therapies [ACTs] and K13 Polymorphism. J Biomed Res Environ Sci. 2020 Aug 13; 1(4): 088-091. doi: 10.37871/jels1124, Article ID: jels1124

Subject area(s)

BiologyVirology

University/Institute

Shri Guru Ram Rai University

References

  1. Siddiqui FA. Malaria control and elimination: How far we are: An Opinion Article. J Biom Biostat. 2016; 7: 321. DOI: 10.4172/2155-6180.1000321
  2. Ahmad S, Ahmad A, Aziz A. A path towards eliminating malaria: Drug resistance a major roadblock? Sci J Biol. 2020; 3: 001-009. DOI:
  3. https://dx.doi.org/10.37871/sjb.id16
  4. WHO. 2018. Status report on artemisinin resistance and ACT efficacy. 2019.
  5. https://tinyurl.com/y45gkx8r
  6. RTS malaria candidate vaccine reduces malaria by approximately one-third in African infants”. Malariavaccine org. Malaria Vaccine Initiative Path. 2013.
  7. https://tinyurl.com/yyhhhlof
  8. Siddiqui FA, Dhawan S, Singh S, Singh B, Gupta P, Pandey A, et al. A thrombospondin structural repeat containing rhoptry protein from Plasmodium falciparum mediates erythrocyte invasion. Cell Microbiol. 2013; 15: 1341-1356. DOI:
  9. https://doi.org/10.1111/cmi.12118
  10. Pandey AK, Reddy KS, Sahar T, Gupta S, Singh H, Reddy EJ, et al. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit straintranscending parasite-neutralizing antibodies. Infect Immun. 2013; 81: 441-451. DOI: 10.1128/IAI.01107-12
  11. Pandey AK, Reddy KS, Sahar T, Gupta S, Singh H, Reddy EJ, et al. Identifcation of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain transcending parasite-neutralizing antibodies. Infect Immun. 2013; 81: 441-451. DOI: 10.1128/IAI.01107-12
  12. Cowman AF, Berry D, Baum J. The cellular and molecular basis for malaria parasite invasion of the human red blood cell. JCB. 2012; 198: 961-971. DOI:
  13. https://doi.org/10.1083/jcb.201206112
  14. Arnott A, Barry AE, Reeder JC. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination. Malar J. 2012; 11: 14. DOI: 10.1186/1475-2875-11-14.
  15. Liang X, Hart KJ, Dong G, Siddiqui FA, Sebastian A, Li X, et al. Puf3 participates in ribosomal biogenesis in malaria parasites. J Cell Sci. 2018; 131: jcs212597. DOI:
  16. https://doi.org/10.1242/jcs.212597
  17. .
  18. Brashear AM, Roobsoong W, Siddiqui FA, Nguitragool W, Sattabongkot J, Lopez-Uribe MM, et al. A glance of the blood stage transcriptome of a Southeast Asian Plasmodium ovale isolate. PLoS Negl Trop Dis. 2019; 13: e0007850. DOI:
  19. https://doi.org/10.1371/journal.pntd.0007850
  20. Dawn A, Singh S, More KR, Siddiqui FA, Pachikara N, Ramdani G, et al. The central role of cAMP in regulating Plasmodium falciparum merozoite invasion of human erythrocytes. PLoS Pathog. 2014; 10: e1004520. DOI:
  21. https://doi.org/10.1371/journal.ppat.1004520
  22. Alam MM, Solyakov L, Bottrill AR, Flueck C, Siddiqui FA, Singh S, et al. Phosphoproteomics reveals malaria parasite
  23. Protein Kinase G as a signalling hub regulating egress and invasion. Nat. Commun. 2015; 6,
  25. https://tinyurl.com/y39c5cv8
  26. McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, et al. Targeting Plasmodium PI(4)K to eliminate malaria. Nature. 2013; 504: 248-253. DOI: 10.1038/nature12782.
  27. Hati S, Madurkar SM, Bathula C, Thulluri C, Agarwal R, Siddiqui FA, et al. Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors. Eur J Med Chem. 2015; 100: 188-196. DOI:
  28. https://doi.org/10.1016/j.ejmech.2015.04.059
  29. PMID:26087029
  30. Hassett MR, Sternberg AR, Roepe PD. Inhibition of human class I vs class III phosphatidylinositol 3’-kinases. Biochemistry. 2017; 56: 4326-4334. DOI:
  31. https://doi.org/10.1021/acs.biochem.7b00413
  32. .
  33. Rocamora F, Zhu L, Liong KY, Dondorp A, Miotto O, Mok S, et al. Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoSPathog. 2018; 14: e1006930. DOI: https:// doi.org/10.1371/journal.ppat.1006930.
  34. Breglio KF, Amato R, Eastman R, Lim P, Sa JM, Guha R, et al. A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient
  35. deprivation. Malar J. 2018; 17: 391. DOI:
  36. https://doi.org/10.1186/s12936-018-2532-x
  37. .
  38. Demas AR, Sharma AI, Wong W, Early AM, Redmond S, Bopp S, et al. Mutations in Plasmodium falciparum actinbinding protein coronin confer reduced artemisinin susceptibility. Proc Natl Acad Sci. 2018; 115: 12799-12804. DOI:
  39. https://doi
  40. .org/10.1073/pnas.1812317115.
  41. Henriques G, van Schalkwyk DA, Burrow R, Warhurst DC, Thompson E, Baker DA, et al. The Mu subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine. Antimicrob Agents Chemother. 2015; 59: 2540-2547. DOI:
  42. https://doi.org/10.1128/AAC
  43. .04067-14.
  44. Siddiqui FA, Cabrera M, Wang M, Brashear A, Kemirembe K, Wang Z,Miao J, et al. Plasmodium falciparum falcipain-2a polymorphisms in Southeast Asia and their association with artemisinin resistance. J Infect Dis. 2018; 218: 434-442. DOI:
  45. https://doi.org/10.1093/infdis/jiy188
  46. .
  47. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014; 505: 50.
  48. https://tinyurl.com/y253zj8p
  49. Siddiqui FA, Boonhok R, Cabrera M, Mbenda HGN, Wang M, Min H, et al. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance. Mbio: 2020; 11: e01134-1119. DOI:
  50. https://doi.org/10.1128/mBio.01134-19
  51. PMID:32098812
  52. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci USA. 2013; 110: 240-245. DOI:
  53. https://doi.org/10.1073/pnas.1211205110
  54. .
  55. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: A cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015; 15: 415-421. DOI:
  56. https://doi.org/10.1016/S1473
  57. -3099(15)70032-0.
  58. Zhang J, Li N, Siddiqui FA, Xu S, Geng J, Zhang J, et al. In vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations. Int J for Parasitol Drugs Drug Resist. 2019; 10: 20-27. DOI: 10.1016/j.ijpddr.2019.04.002
  59. Zhao Y, Ziling Liu, Soe MT, Wang L, Soe TN, Wei H, et al. Genetic Variations Associated with Drug Resistance Markers in Asymptomatic Plasmodium falciparum Infections in Myanmar. Genes. 2019; 10: 692. DOI:
  60. 3390/genes10090692
  61. Wang M, Siddiqui FA, Fan Q, Luo E, Cao Y, Cui L. Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia. Malar J 2016; 15: 537. DOI:
  62. https://doi.org/10.1186/s12936-016-1583-0
  63. Mbenda HGN, Zeng W, Bai Y, Siddiqui FA, Yang Z, Cui L. Genetic diversity of the Plasmodium vivax phosphatidylinositol 3-kinase gene in two regions of the China-Myanmar border. Infect Genet Evol. 2018; 61: 45-52.
  64. https://tinyurl.com/yyhncyo2
  65. Li J, Zhang J, Li Q, Hu Y, Ruan Y, Tao Z, et al. Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes. PLOS Neglected Tropical Diseases. 2020; 14: e0008255. DOI:
  66. https://doi.org/10.1016/j.meegid.2018.02.018
  67. Mbenda HGN, Wang M, Guo J, Siddiqui FA, Hu Y, Yang Z, et al. Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination. Parasites & vectors. 2020; 13: 67. DOI: 10.1186/s13071-020-3934-5
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership